Tosoh Bioscience
Tosoh Bioscience, a leading name in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe, Asia, and North America. Founded in 2003, the company has established itself as a key player in the development and manufacturing of high-quality chromatography products and bioprocessing solutions. With a focus on innovative technologies, Tosoh Bioscience offers a diverse range of core products, including affinity chromatography resins and analytical instruments, which are renowned for their reliability and performance. The company’s commitment to quality and customer satisfaction has solidified its market position, making it a trusted partner for laboratories and biopharmaceutical manufacturers worldwide. Notable achievements include significant advancements in protein purification and a robust portfolio that supports the evolving needs of the life sciences industry.
DitchCarbon Score
How does Tosoh Bioscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tosoh Bioscience's score of 32 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tosoh Bioscience's reported carbon emissions
In 2022, Tosoh Bioscience reported total carbon emissions of approximately 115,909 kg CO2e, comprising 24,891 kg CO2e from Scope 1, 677 kg CO2e from Scope 2, and 89,341 kg CO2e from Scope 3 emissions. Notably, the Scope 1 emissions included 23,873 kg CO2e from mobile combustion, while Scope 3 emissions accounted for significant contributions from employee commuting (3,532 kg CO2e) and waste generated in operations (2 kg CO2e). Comparatively, in 2021, the company’s total emissions were significantly higher at about 392,112 kg CO2e, with Scope 1 emissions at 316,972 kg CO2e, Scope 2 at 4,459 kg CO2e, and Scope 3 at 47,681 kg CO2e. This indicates a substantial reduction in emissions from 2021 to 2022. Tosoh Bioscience has set an ambitious commitment to achieve net zero emissions by 2045, aiming for a 90% reduction across all scopes. This long-term target reflects the company's dedication to sustainability and climate action, aligning with industry standards for reducing greenhouse gas emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 316,972 | 00,000 |
| Scope 2 | 4,459 | 000 |
| Scope 3 | 47,681 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tosoh Bioscience is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
